Skip to main content

Table 4 Factors associated with increased mortality (N = 70)a

From: The Carpentier-Edwards Perimount Magna mitral valve bioprosthesis: intermediate-term efficacy and durability

  Survivors (n = 62) Nonsurvivors (n = 8) P b
AF 14 (23 %) 5 (63 %) 0.02
Ischemic MR 1 (1.6 %) 3 (38 %) 0.03
IABP use 0 (0 %) 2 (25 %) 0.01
Cardiogenic shock 2 (3.2 %) 4 (50 %) 0.001
Cardiac arrest 1 (1.6 %) 2 (25 %) 0.03
Any renal failure 15 (24 %) 6 (75 %) 0.007
  1. AF atrial fibrillation IABP intraaortic balloon pump, MR mitral regurgitation
  2. a Continuous variables expressed as mean ± standard error of the mean (SE); categorical variables, as n (percentage)
  3. b Relationship between dichotomous variables and survival analyzed with 2-tailed Fisher exact tests